Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture. 

This week Lewis Goldberg and Kris Krane sit down with long-time friend of the podcast Adam Smith, Founder and President of the Alliance for Sensible Markets, to talk about the DEA’s historic decision to reclassify cannabis from a Schedule I to Schedule III drug. As a long-time advocate working behind the scenes for decades to reverse the US’s draconian cannabis laws, Adam is cautiously optimistic about this development, noting that one of the most exciting changes will be the increase in research opportunities of cannabis for medical use.

Adam and our hosts also discuss the potential impacts this development will have on the industry and markets, the elimination of the 280E tax, and the potential global rescheduling of cannabis under the UN Single Convention on Narcotics. As the industry awaits what comes next, the team identifies M&A opportunities and clarity on interstate commerce as key areas of interest to watch over the coming months. 

If you are interested in learning more about Adam and how his organization is fighting for a more sustainable legal cannabis industry, visit the links in our show notes and be sure to follow Adam and the Alliance for Sensible Markets on LinkedIn.

So, sit back and enjoy our conversation with Adam Smith, Founder of Alliance for Sensible Markets. 

Links and mentions in the show

• https://www.sensiblemarkets.org/ 

Links to the guest’s company and social media accounts

• Adam Smith LinkedIn: https://www.linkedin.com/in/thatadamsmith/ 
• Alliance for Sensible Markets Twitter: https://twitter.com/statescantwait 

Show Credits:

This episode was hosted by Lewis Goldberg and Kris Krane of KCSA Strategic Communications.

Special thanks to our Program Director, Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X: @KCSAPodcastLabs

Instagram: @KCSAPodcastLabs

LinkedIn: linkedin.com/company/thegreenrushpodcast

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture. 

This week hosts Anne and Phil speak with Ian Dominguez, founder and CIO of Delta Emerald Ventures, a leader in intelligent cannabis investing and industry insight. Ian joins Anne and Phil to talk about the booming market in hemp-derived products, including the growing drinks category, industry consolidation, and the conditions that lead him to start up CannaDataCon, a conference focusing on the intersection of legal cannabis and good data strategy.

Links, mentions, and socials:

• Delta Emerald Ventures: https://www.deltaemerald.com/
• Ian Dominguez on LinkedIn: https://www.linkedin.com/in/iancdominguez/
• CannaDataCon: https://www.cannadatacon.com/
• CannaDataCon on LinkedIn: https://www.linkedin.com/company/88961565
• CannaDataCon on YouTube: https://www.youtube.com/channel/UCrkQ85bVUImGUrY3ZXIJFhg

To learn more about CannaDataCon, check out Ian’s welcome remarks. And to go deeper into hemp beverages, check out Delta Emerald’s view on the category and hear how leading brands describe the regulatory environment.

Show Credits:

This episode was hosted by Phil Carlson and Anne Donohoe of KCSA Strategic Communications.

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

Twitter: @KCSAPodcastLabs

Instagram: @KCSAPodcastLabs

LinkedIn: linkedin.com/company/thegreenrushpodcast

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. 

This week Lewis Goldberg is back for a revisited episode with special guest Ric Flair, Hall-of-Fame wrestler and Founder of Ric Flair Drip, a cannabis brand that offers flower, pre-rolls, edibles and more. Ric joins us this week to discuss his wrestling experiences and perspective on the industry, the parallels of wrestling and cannabis, and his product line Ric Flair Drip, plus a few special questions from fans.

If you are interested in learning more about Ric Flair Drip, head to the links in our show notes. Also, be sure to follow Ric Flair and Ric Flair Drip on Instagram and Twitter to see what he’s up to and to learn more about his great products.

So sit back and enjoy our conversation with the Nature Boy, himself. 

Links and mentions in the show

• https://ricflairdrip.com/ 
• https://www.natureboyricflair.com/ 
• https://carmahold.com/ 

Links to the guest’s company and social media accounts

• Ric Flair Drip Instagram: https://www.instagram.com/ricflairdrip/ 
• Ric Flair Drip Twitter: https://twitter.com/_RicFlairDrip 
• Ric Flair’s Instagram: https://www.instagram.com/ricflairnatureboy/ 
• Ric Flair’s Twitter: https://twitter.com/RicFlairNatrBoy 

Show Credits:

This episode was hosted by Lewis Goldberg of KCSA Strategic Communications. 

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

Twitter: @The_GreenRush 

Instagram: @thegreenrush_podcast

LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/ 

Facebook: https://www.facebook.com/TheGreenRushPodcast/ 

YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. 

This week Phil Carlson and Anne Donohoe talk to Socrates Rosenfeld, CEO and Co-Founder of Jane Technologies. Socrates joins us to discuss his experience in the US Army, having never touched cannabis, and the journey which led to the birth of Jane Technologies and its unique vision on how consumers want to shop.

In this episode, Socrates describes to our hosts his first experience with cannabis and shares his many accomplishments, both personally and professionally, including the innovative solutions Jane offers to brands and retailers as well as consumers.

If you are interested in learning more about Socrates and the latest out of Jane Technologies, visit the links in our show notes. Also, be sure to follow Jane and Socrates on LinkedIn.

So, sit back and enjoy our conversation with Socrates Rosenfeld, CEO and Co-Founder of Jane Technologies.

Links, mentions, and socials:

• Jane Technologies: https://www.iheartjane.com
• Jane Technologies LinkedIn: https://www.linkedin.com/company/jane-technologies-inc
• Jane Technologies Instagram: https://www.instagram.com/_iheartjane
• Jane Technologies Facebook: https://www.facebook.com/iheartjanecom
• Socrates Rosenfeld LinkedIn: https://www.linkedin.com/in/socratesrosenfeld

Show Credits:

This episode was hosted by Phil Carlson and Anne Donohoe of KCSA Strategic Communications.

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X: @KCSAPodcastLabs

Instagram: @KCSAPodcastLabs

LinkedIn: linkedin.com/company/thegreenrushpodcast

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. 

This week Anne Donohoe and Phil Carlson talk to Reason Foundation’s Senior Policy Analyst Michelle Minton and Research Director Geoffrey Lawrence. Michelle and Geoff join us to discuss their drug policy work at Reason Foundation, their latest projects at the organization and their respective journeys to Reason.

In this episode, Michelle and Geoff share insight surrounding their recent policy briefs, the significance of interstate cannabis and “The Drug Legalization Handbook,” as well as perspective on the next big steps towards the integration of psychedelics into the US healthcare system.

If you are interested in learning more about Michelle, Geoff and their work with Reason Foundation, visit the links in our show notes. Also, be sure to follow Reason, Michelle and Geoff on X.

So, sit back and enjoy our conversation with Michelle Minton, Senior Policy Analyst and Geoffrey Lawrence, Research Director at Reason Foundation.

Links, mentions, and socials:

• Reason Foundation: https://reason.org
• Reason Foundation drug policy work: https://reason.org/topics/drug-policy
• Drug Legalization Handbook: https://reason.org/policy-study/the-drug-legalization-handbook
• “The implications of federal cannabis rescheduling”
• “The case for interstate marijuana commerce right now”
• “The stereotype of the lazy, lefty marijuana smoker doesn’t reflect reality”
• “Psychedelics Archives”
• Psychedelic Alpha: “Ibogaine Advocates Seek Ohio Opioid Settlement Funds Following Failure in Kentucky”
• Reason Foundation’s X: https://twitter.com/ReasonFdn
• Michelle Minton’s X: https://twitter.com/michelleminton
• Geoffrey Lawrence’s X: https://twitter.com/GLawNV

Show Credits:

This episode was hosted by Anne Donohoe and Phil Carlson of KCSA Strategic Communications.

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X: @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: linkedin.com/company/thegreenrushpodcast

Facebook: facebook.com/TheGreenRushPodcast 

YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. 

This week Lewis Goldberg and Anne Donohoe talk to Keith Gilmore, President of the Portland Psychedelic Society (PPS), an Oregon nonprofit organization established to raise awareness about psychedelic science by funding and coordinating educational events. Keith joins us to discuss Portland’s progress since Measure 109 and how the city is a leading example of community building in the psychedelic space.

In this episode, Keith shares with our hosts his experience as the president of PPS and highlights the organization’s cornerstone to foster education and establish safe spaces for learning and enlightenment for providers, practitioners and patients alike. 

If you are interested in learning more about Keith and his work with Portland Psychedelic Society, visit the links in our show notes. Also, be sure to follow PPS and Keith on top social media platforms.

So, sit back and enjoy our conversation with Keith Gilmore, President of Portland Psychedelic Society.

Links, mentions, and socials:

• Portland Psychedelic Society: https://www.portlandpsychedelic.org
• Portland Psychedelic Society X: https://twitter.com/pdxpsychedelic
• Portland Psychedelic Society Instagram: https://www.instagram.com/portlandpsychedelic
• Keith Gilmore: https://keithgilmore.com
• Keith Gilmore Instagram: https://www.instagram.com/keithgilmoredotcom
• Keith Gilmore LinkedIn: https://www.linkedin.com/in/keithgilmore
• Keith Gilmore YouTube: http://www.youtube.com/@keith_gilmore

Show Credits:

This episode was hosted by Lewis Goldberg and Anne Donohoe of KCSA Strategic Communications.

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X: @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: linkedin.com/company/thegreenrushpodcast

Facebook: facebook.com/TheGreenRushPodcast 

YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. 

This week Phil Carlson and Anne Donohoe talk to Rebecca Martinez, Founder and Executive Director of Alma Institute. Rebecca joins us to discuss the key moments and influences that brought her from regenerative farming to drug policy, to the founding of Alma Institute, a nonprofit psychedelic training and education facility located in Portland Oregon.

In this episode, our hosts learn more about Alma’s Psychedelic Facilitator Certificate Program, which is open to participants from across the US, Rebecca’s book, “Whole Medicine,” and the formation of Oregon’s Measure 109’s psilocybin services framework. 

If you are interested in learning more about Rebecca and her work with Alma Institute, visit the links in our show notes. Also, be sure to follow Alma and Rebecca on LinkedIn and Instagram.

So, sit back and enjoy our conversation with Rebecca Martinez, Founder and Executive Director of Alma Institute.

Links, mentions, and socials:

• Alma Institute: https://www.almatraining.org
• Donate to Alma Institute: https://www.almatraining.org/donate
• Alma Institute Psychedelic Facilitator Certificate Program: https://www.almatraining.org/programoverview
• Alma Institute Newsletter Sign-up: https://www.almatraining.org/email-signup
• Alma Institute LinkedIn: https://www.linkedin.com/company/alma-institute-non-profit
• Alma Institute Instagram: https://www.instagram.com/almainstitute
• “Whole Medicine: A Guide to Ethics and Harm-Reduction for Psychedelic Therapy and Plant Medicine Communities”
• Rebecca Martinez LinkedIn: https://www.linkedin.com/in/rebecca-martinez-396ab622b
• Rebecca Martinez Instagram: https://www.instagram.com/rebeccamartinezwrites

Show Credits:

This episode was hosted by Phil Carlson and Anne Donohoe of KCSA Strategic Communications.

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X: @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: linkedin.com/company/thegreenrushpodcast

Facebook: facebook.com/TheGreenRushPodcast 

YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. 

This week Anne Donohoe and Nick Opich talk to Dr. Joseph Tucker, CEO of Enveric Biosciences (NASDAQ: ENVB), a biotechnology company dedicated to the development of novel neuroplastogen therapeutics for the treatment of neuropsychiatric disorders. Dr. Tucker joins us to discuss the latest news and milestones for the company, including the selection of EB-003 as its lead candidate in its EVM 301 series, plus advice to the retail investor audience on continuing drug discovery investments in the psych space.

In this episode, Joe and our hosts also discuss psychedelic companies that are leveraging AI and how Enveric’s proprietary AI technology PsyAI™ integrates into the biotech’s research processes.

If you are interested in learning more about Joe and Enveric, visit the links in our show notes. Also, be sure to follow Enveric Biosciences on LinkedIn and X.

So, sit back and enjoy our conversation with Dr. Joseph Tucker, CEO of Enveric Biosciences (NASDAQ: ENVB).

Links, mentions, and socials:

• Enveric Biosciences: https://www.enveric.com
• “30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond – Enveric Biosciences (NASDAQ:ENVB), Cybin (AMEX:CYBN) – Benzinga”
• Enveric Biosciences LinkedIn: https://www.linkedin.com/company/EnvericBio
• Enveric Biosciences X: https://twitter.com/Enveric_bio

Show Credits:

This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications.

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X: @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: linkedin.com/company/thegreenrushpodcast

Facebook: facebook.com/TheGreenRushPodcast 

YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. 

This week Anne Donohoe and Nick Opich talk to Wendy Bronfein, Curio Wellness Co-Founder, Chief Brand Officer and Director of Public Policy, and Rebecca Raphael, Curio’s Chief Revenue Officer. Wendy and Rebecca join us to discuss their journey to starting a family cannabis business, the current state of the cannabis industry in the Maryland market, and how Curio Wellness sets itself apart from competitors.

In this episode, Wendy and Rebecca also share plans to expand Curio’s footprint in Mississippi through the company’s franchise program, as well as their unique insights in the potential re/descheduling of cannabis and industry forecast for the rest of the year.

If you are interested in learning more about Wendy, Rebecca and their work with Curio Wellness, visit the links in our show notes. Also, be sure to follow Curio, Wendy and Rebecca on LinkedIn and other top social media platforms.

So, sit back and enjoy our conversation with Curio Wellness’ Co-Founder, Chief Brand Officer and Director of Public Policy, Wendy Bronfein, and Chief Revenue Officer, Rebecca Raphael.

Links, mentions, and socials:

• Curio Wellness: https://curiowellness.com
• Curio Wellness Careers: https://curiowellness.com/careers
• Curio Wellness LinkedIn: https://www.linkedin.com/company/curio-wellness
• Curio Wellness X: https://twitter.com/curiowellness
• Curio Wellness Instagram: https://www.instagram.com/curiowellnessbrand/
• Wendy Bronfein LinkedIn: https://www.linkedin.com/in/wbronfein
• Rebecca Raphael LinkedIn: https://www.linkedin.com/in/rebecca-bronfein-raphael-448b9646

Show Credits:

This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications.

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X: @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: linkedin.com/company/thegreenrushpodcast

Facebook: facebook.com/TheGreenRushPodcast 

YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. 

This week Anne Donohoe and Nick Opich talk to Eric Offenberger, CEO of Vext Science (CSE:VEXT; OTCQX:VEXTF). Eric joins us this week to discuss the company’s operations and growth since his last time on the pod in February 2023, specifically the Arizona cannabis market and how Vext is navigating the unique challenges and leading the local market in retail traffic and sales.

In this episode, Eric also shares insights about Ohio’s road to adult-use legalization, Vext’s plans for growth in the state, and what he predicts for the local market over the next year.

If you are interested in learning more about Eric and Vext Science, visit the links in our show notes. Also, be sure to follow Vext Science and Eric on LinkedIn to stay up to date on the company’s latest milestones.

So, sit back and enjoy our conversation with Eric Offenberger, CEO of Vext Science.

Links, mentions, and socials:

• Vext Science: https://www.vextscience.com
• Vext Science X: https://twitter.com/Vext_Science   
• Vext Science LinkedIn: https://www.linkedin.com/company/vapen-ltd
• Eric Offenberger LinkedIn: https://www.linkedin.com/in/erincoffenbergercpa

Show Credits:

This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications.

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X: @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: linkedin.com/company/thegreenrushpodcast

Facebook: facebook.com/TheGreenRushPodcast 

YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. 

This week Anne Donohoe and Nick Opich talk to Retired United States Air Force Captain Kimberly Juroviesky, President of Ketamine Taskforce. Kimberly joins us to discuss her military service experience and how it led her to advocating for Veterans and ultimately, the Ketamine TaskForce. Kimberly and the team at Ketamine TaskForce are all volunteers working to increase accessibility to safe care, education, and insurance coverage for all humans in need, including Veterans, first responders and more.

In this discussion, Kimberly shares common concerns and misconceptions among Veterans who are new to therapeutic Ketamine treatments, and tells us about her newest project, Healing Our Heroes Foundation. 

If you are interested in learning more about Ketamine TaskForce or the projects that Kimberley is involved with, visit the links in our show notes. Also, be sure to follow Ketamine TaskForce on LinkedIn and check out the website for ways to get involved.

So, sit back and enjoy our conversation with Kimberly Juroviesky, Retired United States Air Force Captain and President of Ketamine Taskforce.

Links, mentions, and socials:

• Ketamine TaskForce: https://www.ketaminetaskforce.org/
• Six-part docuseries: https://givebutter.com/theforgottenveteran
• Facebook Group: Keta-mine Infusions for Patient Health: https://www.facebook.com/groups/781893918621316
• “Ketamine Infusions: A Patient Guide:” https://www.amazon.com/Ketamine-Infusions-Patients-Everything-Before/dp/B086CB14HP
• “KETAMINE JOURNEYS: An Integration Journal for Your Ketamine Experiences:” https://www.amazon.com/KETAMINE-JOURNEYS-Integration-Ketamine-Experiences/dp/B09TMSBM4Y/ref=sr_1_1?crid=340BO956OMY9D&keywords=ketamine+journey&qid=1648574686&sprefix=Ketamine+j%2Caps%2C108&sr=8-1
• Healing Our Heroes Foundation: https://www.healingourheroesflorida.org/
• Ketamine TaskForce LinkedIn: https://www.linkedin.com/in/ketamine-taskforce-inc-3b12a3201

Show Credits:

This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications.

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X: @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: linkedin.com/company/thegreenrushpodcast

Facebook: facebook.com/TheGreenRushPodcast 

YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true